Product Code: ETC8833827 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Treatment for ARDS in the Philippines includes mechanical ventilation, fluid regulation, prone positioning, and pharmacological agents like corticosteroids. Innovations such as ECMO are available in select tertiary hospitals but remain cost-prohibitive for most patients. Public and private health sector efforts are focusing on capacity building for respiratory therapists and critical care physicians to improve ARDS management outcomes.
The treatment landscape for ARDS in the Philippines is evolving as critical care protocols align with international standards. Pharmacological treatments include corticosteroids, antibiotics, and supportive medications, while mechanical ventilation remains the cornerstone of ARDS management. However, limitations in equipment availability, particularly in rural hospitals, pose challenges. Growth in this market is expected through government investments in healthcare infrastructure and the increasing adoption of advanced treatment algorithms in tertiary care facilities.
Treatment options are restricted by limited critical care infrastructure, including ventilators, ECMO (extracorporeal membrane oxygenation), and sedation management. Access to adjunct therapies such as corticosteroids and prone positioning protocols is inconsistent, and training gaps among ICU staff persist across the system.
The treatment of ARDS includes mechanical ventilation, corticosteroids, and supportive therapies. There is a strong investment case for manufacturing or distributing these products locally, reducing dependency on imports. Additionally, pharmaceuticals targeting inflammation modulation and lung regeneration are gaining attention, presenting room for R&D collaborations and clinical trials. Supporting hospital drug formularies with broader ARDS protocols is also an avenue for pharmaceutical players.
Treatment policies for ARDS focus on equipping hospitals with ventilators and supporting evidence-based protocols for respiratory failure management. The government allocates budgetary resources for procurement of ARDS treatments and supports clinical research to improve patient outcomes. Universal Health Care benefits include coverage of ARDS-related care, ensuring reduced financial burden for patients.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Acute Respiratory Distress Syndrome Treatment Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Acute Respiratory Distress Syndrome Treatment Market - Industry Life Cycle |
3.4 Philippines Acute Respiratory Distress Syndrome Treatment Market - Porter's Five Forces |
3.5 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume Share, By Cause, 2021 & 2031F |
3.7 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Acute Respiratory Distress Syndrome Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Acute Respiratory Distress Syndrome Treatment Market Trends |
6 Philippines Acute Respiratory Distress Syndrome Treatment Market, By Types |
6.1 Philippines Acute Respiratory Distress Syndrome Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Mechanical Ventilation, 2021- 2031F |
6.1.4 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.5 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Antiviral Medication, 2021- 2031F |
6.1.6 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Extracorporeal Membrane Oxygenation (ECMO), 2021- 2031F |
6.1.7 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Tocilizumab, 2021- 2031F |
6.1.8 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Acute Respiratory Distress Syndrome Treatment Market, By Cause |
6.2.1 Overview and Analysis |
6.2.2 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Sepsis, 2021- 2031F |
6.2.3 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Inhalation of Harmful Substances, 2021- 2031F |
6.2.4 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Severe Pneumonia, 2021- 2031F |
6.2.5 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Acute Respiratory Distress Syndrome Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Acute Respiratory Distress Syndrome Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.5 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Philippines Acute Respiratory Distress Syndrome Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Philippines Acute Respiratory Distress Syndrome Treatment Market Import-Export Trade Statistics |
7.1 Philippines Acute Respiratory Distress Syndrome Treatment Market Export to Major Countries |
7.2 Philippines Acute Respiratory Distress Syndrome Treatment Market Imports from Major Countries |
8 Philippines Acute Respiratory Distress Syndrome Treatment Market Key Performance Indicators |
9 Philippines Acute Respiratory Distress Syndrome Treatment Market - Opportunity Assessment |
9.1 Philippines Acute Respiratory Distress Syndrome Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Acute Respiratory Distress Syndrome Treatment Market Opportunity Assessment, By Cause, 2021 & 2031F |
9.3 Philippines Acute Respiratory Distress Syndrome Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Philippines Acute Respiratory Distress Syndrome Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Philippines Acute Respiratory Distress Syndrome Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Acute Respiratory Distress Syndrome Treatment Market - Competitive Landscape |
10.1 Philippines Acute Respiratory Distress Syndrome Treatment Market Revenue Share, By Companies, 2024 |
10.2 Philippines Acute Respiratory Distress Syndrome Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |